PROMIS NEUROSCIENCES IDENTIFIES NOVEL ANTIBODY CANDIDATES FOR MULTIPLE SYSTEM ATROPHY

TORONTO, Ontario and CAMBRIDGE, Mass. — October 8, 2019 — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, has identified several novel antibody candidates for Multiple System Atrophy (MSA), a severe, Parkinson’s-like disease caused by toxic, misfolded forms of the protein alpha-synuclein. The new antibody candidates join ProMIS’ strong pipeline of antibodies that demonstrate high selectivity for toxic misfolded proteins, implicated as a root cause of several neurodegenerative diseases, including Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis (ALS). MORE>>

MIDAC FC INSECTICIDE RECEIVES EPA REGISTRATION

Potato and sugarbeet growers who want long-lasting control of sucking and chewing pests have a unique new tool. The US Environmental Protection Agency recently registered Midac FC (imidacloprid) and it becomes the newest addition to Vive Crop Protection’s product lineup. MORE>>

JOHN SINCLAIR TO SPEAK AT ONTARIO HEALTH IT CONFERENCE – HIMSS ONTARIO CHAPTER

John Sinclair, President at Novari Health and a Certified Professional in Health Information and Management Systems (CPHIMS-CA) will be presenting at the Ontario Health IT Conference in Toronto on Thursday, October 3, 2019. Mr. Sinclair’s presentation focuses on Ontario success stories in virtual care, eReferral, central intake, and wait list management. He will share real world and live examples of how Ontario is improving access to care across the care continuum. MORE>>

PROMIS NEUROSCIENCES EXECUTIVE CHAIRMAN EUGENE WILLIAMS TO SPEAK ON PANEL AT FALL INVESTOR SUMMIT

TORONTO, Ontario and CAMBRIDGE, Mass. —September 16, 2019 — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced that Executive Chairman, Eugene Williams will participate on an executive panel at the Fall Investor Summit being held today at noon at the JW Marriot Essex House, 160 Central Park South, New York, NY.  MORE>>

INTELLIJOINT SURGICAL RANKS 13TH ON THE 2019 STARTUP 50 LIST OF CANADA’S TOP NEW GROWTH COMPANIES BY CANADIAN BUSINESS AND MACLEAN’S

September 12, 2019 (Waterloo, ON) – Today, Canadian Business and Maclean’s ranked Intellijoint Surgical®13th on the 2019 Startup 50 ranking of Canada’s Top New Growth Companies. Serving as a companion list to the longstanding Growth 500 ranking of Canada’s Fastest-Growing Companies and produced by Canada’s premier business and current affairs media brands, the Startup 50 ranks younger companies on two-year revenue growth. MORE>>